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I.	  Introduction	  
	   For	  many	  years,	  organic	  chemists	  have	  relied	  on	  the	  use	  of	  transition	  metal	  catalysts	  to	  drive	  a	  wide	  variety	  of	   reactions,	   and	   their	  use	  has	  been	  beneficial	   in	   the	   synthesis	  of	  pharmaceuticals	   and	   other	   aspects	   of	   the	   chemical	   industry.	   However,	   transition	   metal	  catalysis	   is	  not	  a	  sustainable	  method	  due	   to	  high	  cost	  and	   the	   limited	  quantities	  of	  many	  catalytic	  metals	  on	  the	  earth.	  Furthermore,	  transition	  metal	  catalysis	  is	  not	  favorable	  due	  to	  the	  high	   toxicity	   of	  metals	   and	   reaction	  waste.	  Throughout	   the	  past	   few	  years,	   there	  has	  been	  a	  push	  to	  explore	  alternative,	  environmentally	  benign	  catalytic	  complexes.	   	  Methods	  employing	  calcium	  complexes	  have	  been	  very	  promising.	  	  Calcium	  is	  a	  promising	  catalytic	  species	  because	  it	  is	  electropositive	  and	  has	  a	  large	  atomic	  radius	  that	  allows	  for	  a	  number	  of	  coordination	  sites.1	  Additionally,	  calcium	  is	   the	  fifth	  most	  abundant	  and	  easily	  accessible	  element	  on	  the	  earth,	  and,	  therefore,	  would	  be	  a	  sustainable	   option	   for	   catalysis.2	  Calcium	   complexes	   have	   been	   successful	   in	   catalyzing	   a	  number	   of	   desirable	   reactions	   including	   ring	   opening	   polymerizations	   and	   4π−	  electrocyclizations.3	  Their	   Lewis-­‐acidic	   nature	   suggests	   a	   potential	   for	   a	   wide	   range	   of	  applications.4	  	  	   In	   an	   effort	   to	   synthesize	   nitrogen-­‐containing	   biologically	   active	   compounds,	   the	  reactivity	  of	  the	  nitrone	  (Figure	  1)	  has	  been	  applied	  to	  a	  variety	  of	  reactions	  and	  has	  been	  found	   to	   be	   a	   very	   valuable	   reagent.5	  These	   carbonyl-­‐derivative	   compounds	   are	   easily	  synthesized	   and,	   therefore,	   are	   an	   accessible	   starting	   material	   for	   the	   production	   of	  common	  motifs.	   Nitrones	   have	   a	   1,3-­‐dipole	   and	   an	   internal	   iminium	   species	   that	  makes	  them	   highly	   reactive	   electrophiles. 6 	  Nitrones	   have	   been	   substrates	   in	   a	   number	   of	  reactions,	   including	  [3+2]	  cycloadditions.6,7	  Nitrones	  have	  been	  shown	  to	  coordinate	  with	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II.	  1,3-­‐Dipolar	  Cycloaddition	  
	   Cycloaddition	  reactions	  have	  been	  widely	  studied	  and	  utilized	  by	  organic	  chemists	  due	  to	  their	  transition	  state	  predictability,	  which	  allows	  for	  selective	  additions	  in	  molecule	  synthesis.8	   A	   1,3-­‐dipolar	   cycloaddition	   reaction	   utilizes	   the	   1,3-­‐dipole,	   or	   three-­‐atom	  structure	  with	  positive	  and	  negative	  charges	  on	  either	  terminus,	  of	  a	  molecule	  to	  form	  five-­‐membered	  heterocycles.9	  	  Cyclopropanes	  have	  been	  shown	  to	  be	  successful	  substrates	  for	  this	  reaction.	  In	  particular,	  their	  cycloaddition	  to	  nitrones	  has	  been	  found	  to	  be	  an	  excellent	  method	   for	   the	   synthesis	   of	   heterocyclic	   ring	   systems	   and	   carbon	   skeleton	   construction	  (eq.	  1).8,10	  	  	  
	   Cyclopropanes	   are	   excellent	   substrates	   for	   1,3-­‐dipolar	   cycloadditions	   because	   the	  cyclopropyl	  ring	  (Figure	  2)	  has	  significant	  ring	  strain,	  and	  the	  relief	  of	  this	  ring	  strain	  is	  a	  major	  thermodynamic	  driving	   force.10	  Furthermore,	   the	  single	  bonds	  of	   the	  cyclopropane	  act	   similarly	   to	   carbon-­‐carbon	  π-­‐bonds	   and	   are	   susceptible	   to	   nucleophillic	   attack	   in	   the	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   3	  
presence	  of	  electron-­‐withdrawing	  groups.10	  Donor-­‐acceptor	  cyclopropanes	  contain	  both	  an	  electron-­‐withdrawing	   and	   an	   electron-­‐donating	   group	   and,	   therefore,	   make	   excellent	  electrophiles	   in	   the	   1,3-­‐dipolar	   cycloaddition	   reaction.	   The	   use	   of	   cyclopropanes	   can	   be	  advantageous	   due	   to	   the	   ability	   for	   cyclopropanes	   to	   act	   as	   a	   "synthetic	   wedge	   tool,"	  allowing	  for	  formation	  of	  a	  one	  carbon	  homologue	  of	  the	  product	  acquired	  from	  alkenes.10	  Weakening	   of	   the	   cyclopropyl	   bonds	   has	   been	   achieved	   by	   Lewis	  Acids,	   and	   our	   lab	   has	  been	   successful	   in	   the	   activation	   of	   donor-­‐acceptor	   (DA)	   cyclopropanes	   with	   calcium	  complexes.8,11	  	  	  	  	   	  	  	  	   The	   products	   of	   this	   reaction,	   tetrahydro-­‐1,2-­‐oxazines,	   are	   desirable	   biologically	  active	   compounds	   with	   potential	   applications	   in	   the	   pharmaceutical	   industry.	   The	  desirability	   of	   this	   product	   and	   our	   lab's	   success	  with	   calcium	   catalysis	   in	   cyclopropane	  reactions	   prompted	   us	   to	   explore	   the	   use	   of	   calcium	   for	   the	   addition	   of	   nitrones	   to	   DA	  cyclopropanes	   (equation	   2).	   We	   began	   by	   testing	   a	   variety	   of	   commercially	   available	  calcium	   (II)	   complexes.	   Calcium	   iodide	   (CaI2)	   was	   initially	   shown	   to	   be	   reactive	   with	  cyclopropane	   1	   and	   nitrone	   2,	   and	   the	   products	   was	   found	   to	   have	   a	   1:4	   cis-­‐trans	  diastereomeric	  ratio.	  Further	  optimization	  with	  nitrone	  4	  (Figure	  3)	  resulted	  in	  the	  ability	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   4	  
to	   decrease	   catalyst	   loading,	   nitrone	   equivalents,	   and	   reaction	   temperature	   while	  increasing	   the	   diastereomeric	   ratio	   to	   >99:1.	   Subsequently,	   the	   reaction	   scope	   was	  explored	  for	  variations	  of	  cyclopropane	  1	  as	  well	  as	  nitrones	  2	  and	  4.	  	  
	  
	  
1.	  Results	  and	  Discussion	  





Figure	  3.	  N-­‐phenyl	  Nitrone	  
	   5	  
slight	   increase	   in	   conversion	   (88%)	   at	   this	   temperature	   when	   catalyst	   loading	   was	  






























































































































a Reactions were run with 0.3 mmol of 1 and 0.33 in dry solvents for 19-24 h.


































Table	  1.	  N-­‐methyl	  Nitrone	  Reaction	  Optimization	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to	  product	  was	  maintained	  at	  5%	  Ca(OTf)2,	  and	  decreased	  slightly	  (95%)	  at	  2%	  Ca(OTf)2.	  Since	   catalyst	   loading,	   and	   reaction	   temperature	   could	   be	   decreased	   while	  diastereoselectivity	  increased	  with	  the	  N-­‐phenyl	  nitrone,	  it	  was	  used	  in	  the	  place	  of	  the	  N-­‐
methyl	   nitrone	   in	   the	   reaction	  optimization	   condiitions	   .	  As	  determined	  by	   these	   studies,	  the	  reaction	  conditions	  for	  the	  addition	  of	  N-­‐phenyl	  nitrone	  4	   to	  cyclopropane	  1	  were	  1.0	  equivalents	   of	   cyclopropane	   and	   1.2	   equivalents	   of	   nitrone	   in	   the	   presence	   of	   2	   mol%	  Ca(OTf)2	   in	   1.0	  M	  CH3CN	  at	   50	   °C.	  Under	   these	   conditions,	   an	   isolated	   yield	   of	   94%	  was	  
obtained	  for	  product	  5	  with	  a	  66:1	  cis	  to	  trans	  diastereomeric	  ratio.	  	  























a Reactions were run with 0.3 mmol of 1 and 0.33 in dry solvents for 19-24 h.










































Table	  2.	  N-­‐phenyl	  Nitrone	  Reaction	  Optimization	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and	   87%	   yields,	   respectively.	   Cycloaddition	   products	   7e	   and	   7f	   from	   electron-­‐deficient	  cyclopropanes	   6e	   and	   6f	   were	   isolated	   in	   slightly	   higher	   yields	   (91%	   and	   93%,	  respectively)	   than	   electron-­‐rich	   cyclopropanes	   as	   expected	   due	   to	   increased	  electrophillicity	  of	  the	  cyclopropane.	  Surprisingly,	  cyclopropane	  6g	  was	  less	  reactive	  than	  other	  electron-­‐deficient	  species	  and	  tetrahydro-­‐1,2-­‐oxazine	  7g	  was	  isolated	  in	  a	  78%	  yield	  despite	   increasing	   catalyst	   loading	   to	   5	   mol%.	   	   Electron	   rich	   cyclopropane	   6b	   showed	  increased	  diastereoselectivity	  (>99:1)	  towards	  the	  cis	  product	  while	  all	  other	  electron	  rich	  and	  electron	  deficient	  cyclopropanes	  showed	  a	  decrease	  in	  diastereoselectivity	  (27-­‐29:1),	  



























































































a Diastereomeric ratios were determined by 1H NMR
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which	  still	  favored	  the	  cis	  product.	  Substitution	  at	  the	  ortho	  position	  as	  opposed	  to	  the	  para	  position	   showed	   no	   effect	   on	   the	   yield	   or	   diastereoselectivity	   (entry	   5).	   Substitutions	   of	  heterocyclic	  groups	  on	  the	  cyclopropane	  were	  also	  found	  to	  be	  reactive	  and	  products	  7a,h-­‐
j	   for	   cyclopropanes	   6a,h-­‐j	   were	   isolated	   in	   excellent	   yields	   (86%-­‐99%)	   with	   increased	  selectivity	  for	  the	  cis	  product	  (52-­‐>99:1).	  	  
















































a Diastereomeric ratios were determined by 1H NMR
Table	  4.	  N-­‐phenyl	  Nitrone	  Scope	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nitrones	   (17-­‐20:1).	   Substituting	   the	   N-­‐phenyl	   nitrone	   with	   a	   heteroaromatic	   group	  produced	   product	   9d	   in	   a	   lower	   yield	   (74%)	   but	   with	   increased	   diastereoselectivity	   in	  favor	  of	  the	  cis	  product	  (>99:1).	  	  	   Reactivity	  and	  diastereoselectivity	  were	  also	  explored	  for	  the	  addition	  of	  various	  N-­‐
methyl	   nitrones	   to	   cyclopropane	   1,	   seen	   in	   Table	   5.	   Nitrones	   with	   electron-­‐donating,	  electron-­‐withdrawing,	   and	   heterocyclic	   substituents	   underwent	   cycloadditon	   with	   the	  model	   DA	   cyclopropane	   to	   produce	   tetrahydro-­‐1,2-­‐oxazine	   products	   11a-­‐c	   in	   excellent	  yields	  (83-­‐92%).	  All	  N-­‐methyl	  nitrones	  in	  our	  scope	  displayed	  the	  same	  slight	  selectivity	  for	  the	  cis	  product	  (3:1)	  as	  the	  reaction	  with	  nitrone	  2	  and	  cyclopropane	  1.	  	  
	  2.	  Conclusion	  	   The	   results	   of	   the	   addition	   of	   nitrones	   to	  DA	   cyclopropanes	   provide	   a	   convenient	  and	  effective	  method	  for	  the	  preparation	  of	  diastereoselective	  tetrahydro-­‐1,2-­‐oxazines.	  The	  synthesis	   of	   this	   product	   is	   highly	   valuable	   because	   tetrahydro-­‐1,2-­‐oxazines	   have	   been	  used	   for	   a	   number	   of	   natural	   product	   syntheses,	   including	   the	   total	   synthesis	   of	   (+)-­‐














































a Diastereomeric ratios were determined by 1H NMR
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phyllantidine	   and	   (+)-­‐nakadormarin.8,12	  Furthermore,	   tetrahydro-­‐1,2-­‐oxazines	   have	   been	  critical	   for	   the	   synthesis	   of	   FR900482,	   an	   antitumor	  antibiotic.8	  Our	  method	  provides	   an	  inexpensive	   and	   environmentally	   benign	   process	   for	   the	   synthesis	   of	   this	   product,	   and	  further	  demonstrates	  the	  effectiveness	  of	  Ca(II)	  complexes	  as	  Lewis	  acid	  catalysts.	  	  
III.	  Mukaiyama-­‐Mannich	  Reaction	  
	   The	   Mannich	   reaction,	   the	   nucleophillic	   attack	   of	   an	   iminium	   ion	   by	   an	   enolized	  carbonyl	  compound	  has	  been	  extensively	  studied	  and	  successfully	  utilized	  to	  form	  carbon–carbon	  bonds.13	  When	  the	  enolized	  carbonyl	  compound	  is	  replaced	  with	  a	  silyl	  enol	  ether,	  this	  reaction	  comes	  to	  be	  known	  as	  the	  Mukaiyama-­‐Mannich	  reaction.	  Silyl	  enol	  ethers	  are	  beneficial	  substrates	  because	  they	  are	  highly	  regio-­‐	  and	  stereoselective.14	  This	  reaction	  has	  a	   wide	   variety	   of	   applications,	   including	   the	   synthesis	   of	   a	   precursor	   to	   an	   analogue	   of	  naturally	  occuring	  (+)-­‐goniofurfurone	  and	  the	  efficient	  entry	  into	  the	  core	  of	  alkaloids	  from	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shown	   the	   successful	   catalysis	   of	   1,3-­‐dipolar	   cycloadditions	  with	   Lewis	   Acid	   catalysts	   to	  form	   isoxoladines	   (Scheme	  1,	  pathway	  1).5,18However,	   the	   synthesis	  of	  β-­‐amino	   carbonyl	  compounds	  can	  also	  be	  achieved	   from	  these	  substrates	   through	   the	  Mukaiyama-­‐Mannich	  addition	   pathway	   (pathway	   2).13,19	  This	   pathway	   is	   desirable	   due	   the	   biologically	   active	  nature	  of	  β-­‐amino	  alcohols,	  a	  β-­‐amino	  carbonyl	  derivative.20	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a Reactions were run with 0.3 mmol of 4 and 0.45 mol of 12 in dry solvents for 19-24 h.
b Conversions were determined by 1H NMR.
Table	  6.	  Reaction	  Optimization	  
	   13	  
all	   found	   to	   maintain	   catalytic	   activity.	   Furthermore,	   the	   change	   in	   solvent	   resulted	   in	  100%	   conversion	   to	   the	   desired	   β-­‐amino	   alcohol	   at	   only	   2%	   catalyst	   loading	   after	  extending	  the	  reaction	  to	  run	  for	  24	  hours	  (entry	  8).	  	  	   Despite	   achieving	   100%	   conversion	   to	   product	   13,	   our	   attempts	   to	   isolate	   it	   for	  yield	   were	   hindered	   by	   the	   formation	   of	   acetophenone,	   a	   byproduct	   caused	   by	   the	  breakdown	  of	  the	  silyl	  enol	  ether,	  and	  by	  the	  difficulty	  in	  separating	  the	  β-­‐amino	  carbonyl	  from	  excess	  starting	  materials.	  By	  monitoring	  the	  reaction	  via	  1H	  NMR	  in	  d-­‐acetonitrile,	  the	  reaction	  was	   found	   to	   have	   reached	   completion	   after	   4	   hours.	   Determined	   by	   the	   above	  studies,	   our	   optimized	   reaction	   conditions	   were	   1.0	   equivalents	   of	   nitrone	   4	   and	   1.5	  equivalents	   silyl	   enol	   ether	  12	   in	   the	   presence	   of	   2%	  Ca(OTf)2	   in	   1.0M	  CH3CN	  heated	   at	  50°C	  for	  4	  hours.	  For	  this	  reaction,	  we	  were	  able	  to	  maximize	  the	  isolated	  yield	  to	  95%.	  
	   1.2	  Nitrone	  Scope	  	  After	  optimizing	  the	  reaction,	  the	  scope	  of	  N-­‐phenyl	  nitrones	  was	  examined.	  The	  addition	  of	  various	  aryl-­‐substituted	  nitrones	  was	  explored,	  the	  results	  of	  which	  are	  presented	  in	  Table	  7.	  Electron-­‐rich,	  electron-­‐deficient,	  sterically	  encumbered,	  and	  heteroaromatic	  nitrones	  8a-­‐
i	  were	  synthesized	   in	  our	   lab	   following	   literature	  procedure.	  The	  optimization	  conditions	  	  for	  the	  exploration	  of	  this	  scope	  were	  altered	  to	  run	  the	  reaction	  for	  24	  hours.	  Aryl	  nitrones	  with	   electron-­‐donating	   and	   electron-­‐withdrawing	   substituents	   both	   demonstrated	  excellent	   reactivity.	   Electron-­‐rich	   nitrones	   8a	   and	   8b	   reacted	   in	   93%	   and	   95%	   yield,	  respectively,	   and	   electron-­‐deficient	   nitrones	   8e	   and	   8c	   reacted	   in	   94%	   and	   96%	   yield,	  respectively.	  Sterically	  encumbered	  nitrones	  8f	  and	  8g	  reacted	  in	  slightly	  lower	  yields	  than	  electron-­‐rich	   and	   electron-­‐deficient	   nitrones	   (84%-­‐93%).	   Nitrones	   8h,	   8i,	   and	   8d	   with	  heteroaromatic	   substituents	   were	   also	   found	   to	   be	   reactive,	   but	   in	   lower	   yields	   (72%-­‐
	   14	  
93%).	   The	   lower	   yield	   of	  14d	   can	   be	   attributed	   to	   the	   difficulty	   separating	   the	  β-­‐amino	  carbonyl	  from	  the	  starting	  material.	  N-­‐methyl	  nitrone	  2	  was	  also	  tested,	  but	  was	  unreactive.	  All	   products	   from	   silyl	   enol	   ether	   12	   except	   for	   13	   and	   14c	   were	   found	   to	   have	   trace	  amounts	   of	   azoxybenzene	   and	   disiloxane	   byproducts.	   Disiloxane	   is	   formed	   from	   the	  reaction	  of	  silicon	  biproducts	  with	  oxygen	  from	  water	  or	  the	  nitrone.	  It	  is	  unknown	  at	  this	  time	  how	  azoxybenzene	  is	  formed	  in	  this	  reaction.	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  7.	  N-­‐phenyl	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Table	  8.	  Silyl	  Enol	  Ether	  Scope	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an	  88%	  yield	  under	  the	  original	  optimized	  conditions.	  Silyl	  enol	  ether	  15c	  formed	  product	  
16c	  when	  reaction	  conditions	  were	  adjusted	  to	  5%	  catalyst	  loading	  at	  70°C	  for	  24	  hours	  in	  a	  58%	  yield.	  Product	  16b	  showed	  moderate	  diastereoselectivity	  for	  the	  anti	  diastereomer	  in	  a	  3:1	  ratio,	  while	  product	  16c	  showed	  moderate	  diastereoselectivity	  for	  the	  syn	  product	  in	  a	  2:1	  ratio.	  	  
2.	  Proposed	  Catalytic	  Cycle	  	  
	   The	  catalytic	  ability	  of	  calcium(II)	  complexes	  was	  explored	  due	  to	  the	  Lewis	  acidic	  nature	  of	  the	  metal,	  which	  we	  believed	  would	  be	  effective	  in	  driving	  the	  desired	  reaction.	  Scheme	   2	   illustrates	   the	   proposed	   mechanism	   for	   Mukaiyama-­‐Mannich	   addition	   to	  nitrones.	  First,	  Ca(OTf)2	  coordinates	  with	  the	  nitrone,	  likely	  through	  exchange	  of	  one	  of	  the	  triflate	  ligands,	  causing	  an	  increase	  in	  electrophilicity.	  The	  nucleophilic	  double	  bond	  of	  the	  silyl	  enol	  ether	  can	  then	  add	  to	  the	  nitrone	  at	  the	  alpha	  position.	  The	  release	  of	  the	  calcium	  species	   can	   be	   envisioned	   in	   two	  ways.	  We	   believe	   that	   a	   silyl	   transfer	   occurs,	   possibly	  facilitated	  by	  the	  triflate	  anion,	  and	  our	  product	  forms	  directly	  with	  the	  release	  of	  calcium.	  However,	  there	  is	  a	  possibility	  that	  the	  formation	  of	  the	  silyl	  acetal	  occurs,	  and	  subsequent	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breakdown	  during	  the	  reaction	  causes	  the	  production	  of	  our	   final	  product.	   	  However,	   the	  silyl	  acetal	  was	  not	  observed	  in	  the	  crude	  1H	  NMR	  spectrum.	  	  
3.	  Conclusions	  
	   The	  results	  of	  this	  study	  demonstrate	  the	  excellent	  ability	  of	  calcium	  to	  catalyze	  the	  Mukaiyama-­‐Mannich	   reaction	   of	   nitrones	   and	   silyl	   enol	   ethers.	   Our	   methods	   provide	   a	  pathway	  for	  synthesis	  of	  β-­‐amino	  carbonyls	  with	  high	  yield	  as	  well	  as	  the	  ability	  to	  utilize	  cyclic	   and	   bulky	   silyl	   enol	   ethers.	   The	   success	   of	   calcium	   in	   this	   reaction	   allows	   for	  convenient	   and	   inexpensive	   preparation	   of	   β-­‐amino	   carbonyls	   and	   a	   method	   for	   the	  synthesis	  of	  β-­‐amino	  alcohol	  precursors	  under	  environmentally	  benign	  conditions.	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Appendices	  
	  
1.	  Experimental	  Information	  for	  Addition	  of	  Nitrones	  to	  Electron	  
Deficient	  Cylopropanes	  
	  
General	  Information.	  Unless	  otherwise	  noted,	  all	  commercial	  materials	  were	  used	  without	   purification.	   Calcium	   triflate	   and	  N,ɑ-­‐Diphenyl	   nitrone	   (4)	  were	   obtained	  from	  commercial	  sources	  and	  used	  without	   further	  purification.	  DA	  cyclopropanes	  and	  nitrones	  were	   synthesized	   according	   to	   literature	  procedures.	  Diastereomeric	  ratios	  were	   determined	   by	   1H	  NMR.	   	   NMR	   data	   for	  major	   diastereomer	   has	   been	  reported.	  	  Minor	  diastereomers	  were	  not	  able	  to	  be	  isolated.	  	  	  	  
General	  Procedure	  for	  the	  Addition	  of	  Nitrones	  to	  Cyclopropanes:	  In	  an	  inert	  glovebox,	  calcium	  triflate	  (6.8	  mg,	  0.02	  mmol,	  0.02	  equiv)	  was	  added	  to	  a	  3	  mL	  conical	   glass	  vial	  with	  a	   stir	  bar.	  After	  vial	  was	   removed	   from	   the	  glovebox,	  cyclopropane	  (1	  mmol,	  1.0	  equiv),	  nitrone	  (1.2	  mmol,	  1.2	  equiv)	  and	  dry	  MeCN	  (1.0	  mL,	   1.0	  M)	  were	   added.	   The	   reaction	   solution	  was	   heated	   to	   50	   or	   70	   °C	   and	   the	  reaction	  progress	  was	  monitored	  by	  TLC.	  Upon	   completion,	   the	  vial	  was	   removed	  from	  the	  heat,	  and	  cooled	  to	  room	  temperature	  while	  stirring.	  The	  reaction	  was	  then	  loaded	  directly	   onto	   a	   silica	   gel	   column	  and	  purified	  by	   flash	   chromatography	   (5-­‐20%	  EtOAc	  in	  hexanes).	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  Dimethyl	   2-­‐methyl-­‐3,6-­‐diphenyl-­‐1,2-­‐oxazinane-­‐4,4-­‐
dicarboxylate	   (3):	  white	   solid,	  mp	  84-­‐86	   °C	   (345.7	  mg,	  94%	  yield);	  1H	  NMR	  (300	  MHz,	  CDCl3):	  δ	  7.66	  –	  7.57	  (m,	  2H),	  7.54	  –	  7.26	  (m,	  8H),	  4.89	  (dd,	  J	  =	  11.7,	  3.1	  Hz,	  1H),	  4.84	  (s,	  1H),	  3.89	  (s,	  3H),	  3.39	  (s,	  3H),	  2.74	  (dd,	   J	  =	  14.5,	  11.8	  Hz,	  1H),	  2.63	  (dd,	   J	  =	  14.4,	   3.2	  Hz,	   1H),	   2.54	   (s,	   3H);	   13C	  NMR	   (126	  MHz,	   CDCl3):	   δ	   170.3,	   168.5,	   140.2,	  134.8,	  130.9,	  128.6,	  128.2,	  128.1,	  128.1,	  126.4,	  77.9,	  68.0,	  59.4,	  53.3,	  52.4,	  43.4,	  31.1.	  Spectral	  data	  was	  consistent	  with	  reported	  literature	  values.i	  	  	  
	  Dimethyl	   6-­‐(4-­‐methoxyphenyl)-­‐2-­‐methyl-­‐3-­‐phenyl-­‐1,2-­‐
oxazinane-­‐4,4-­‐dicarboxylate	  (10a):	  	  white	  solid,	  mp	  86-­‐91	  °C	  (343.2	  mg,	  86%	  yield).	  1H	  NMR	  (300	  MHz,	  CDCl3):	  δ	  7.61	  (dd,	  J	  =	  6.5,	  3.0	  Hz,	  2H),	  7.48	  –	  7.37	  (m,	  2H),	  7.39	  –	  7.26	  (m,	  3H),	  7.01	  –	  6.89	   (m,	  2H),	  4.89	  –	  4.77	   (m,	  2H),	  3.88	   (s,	  3H),	  3.83	   (s,	  3H),	  3.39	  (s,	  3H),	  2.75	  (dd,	  J	  =	  14.4,	  12.2	  Hz,	  1H),	  2.61-­‐2.53	  (m,	  1H),	  2.53	  (s,	  3H),	  1.29	  –	  1.18	  (m,	  1H);	  13C	  NMR	  (126	  MHz,	  CDCl3):	  δ	  170.4,	  168.5,	  159.6,	  130.9,	  128.2,	  128.0,	  128.0,	  120.0,	  114.0,	  77.6,	  68.0,	  59.4,	  55.3,	  53.3,	  52.4,	  43.4,	  30.7,	  15.3;	  IR	  (cm-­‐1):	  3060,	  3028,	   2955,	   2873,	   2841,	   1725,	   1587,	   1490,	   1252,	   1239,	   1181,	   1081.	   	   HRMS	   (+ve	  ESI/APCI	  TOF,	  C22H26NO6(MH+))	  	  Calc’d	  400.1755,	  Measured	  Mass	  	  400.1754.	  	  
	  Dimethyl	   6-­‐(4-­‐chlorophenyl)-­‐2-­‐methyl-­‐3-­‐phenyl-­‐1,2-­‐
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=	  5.6	  Hz,	  2H),	  7.47	  –	  7.28	  (m,	  7H),	  4.85	  (m,	  2H),	  3.89	  (s,	  3H),	  3.38	  (s,	  3H),	  2.78	  –	  2.57	  (m,	  2H),	  2.53	  (s,	  3H);	  13C	  NMR	  (75	  MHz,	  CDCl3):	  δ	  170.2,	  168.3,138.7,	  134.7,	  133.8,	  130.8,	  128.7,	  128.3,	  128.1,	  127.7,	  67.8,	  59.4,	  53.4,	  52.5,	  43.4,	  31.0;	   IR	  (cm-­‐1):	  3037,	  2993,	  2955,	  2892,	  1736,	  1492,	  1429,	  1255,	  1169,	  1150.ii	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C21H23NO5Cl(MH+))	  	  Calc’d	  404.1259,	  Measured	  Mass	  	  404.1265.	  	  
	  Dimethyl	   6-­‐(benzo[d][1,3]dioxol-­‐5-­‐yl)-­‐2-­‐methyl-­‐3-­‐phenyl-­‐
1,2-­‐oxazinane-­‐4,4-­‐dicarboxylate	  (10c):	  white	  solid,	  mp	  115-­‐117	  °C380.8	  mg,	  92%	  yield;	  1H	  NMR	  (300	  MHz,	  CDCl3):	  δ	  7.64	  –	  7.54	  (m,	  2H),	  7.39	  –	  7.26	  (m,	  3H),	  7.04	  –	  6.90	  (m,	  2H),	  6.84	  (d,	  J	  =	   8.0	  Hz,	   1H),	   5.98	   (s,	   2H),	   4.85	   –	   4.73	   (m,	   2H),	   3.88	   (s,	   3H),	  3.39	  (s,	  3H),	  2.78	  –	  2.49	  (m,	  2H),	  2.52	  (s,	  3H);	  13C	  NMR	  (126	  MHz,	  CDCl3):	  δ	  170.3,	  168.4,	  147.8,	  147.4,	  134.7,	  130.9,	  128.3,	  128.1,	  120.1,	  108.3,	  107.3,	  101.1,	  77.8,	  59.4,	  53.3,	  52.4,	  43.4,	  31.0;	   IR	   (cm-­‐1):	  3063,	  3025,	  2952,	  2873,	  1726,	  1596,	  1487,	  1234,	  1171,	   1070,	   751.	   	   HRMS	   (+ve	   ESI/APCI	   TOF,	   C22H24NO7(MH+))	   	   Calc’d	   414.1547,	  Measured	  Mass	  	  414.1545.	  	  
Dimethyl	   2,3,6-­‐triphenyl-­‐1,2-­‐oxazinane-­‐4,4-­‐
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1H),	  2.79	  (ddd,	  J	  =	  14.4,	  2.7,	  0.9	  Hz,	  1H);	  13C	  NMR	  (126	  MHz,	  CDCl3):	  δ	  170.1,	  168.3,	  148.6,	   139.4,	   135.0,	   130.4,	   128.6,	   128.5,	   128.3,	   128.1,	   128.0,	   126.5,	   121.6,	   115.8,	  78.8,	   65.8,	   59.6,	   53.5,	   52.6,	   31.7.	   	   Spectral	   data	   was	   consistent	   with	   reported	  literature	  values.iii	  	  
Dimethyl	   6-­‐(benzo[d][1,3]dioxol-­‐5-­‐yl)-­‐2,3-­‐diphenyl-­‐
1,2-­‐oxazinane-­‐4,4-­‐dicarboxylate	   (7a):	   	   white	   solid,	   mp	  152-­‐155	   °C	   (474.7	   mg,	   99%	   yield);	   1H	   NMR	   (300	   MHz,	  CDCl3):	  δ	  7.63	  –	  7.50	  (m,	  2H),	  7.22-­‐7.06	  (m,	  8),	  7.02	  (ddd,	  J	  =	  8.0,	  1.8,	  0.6	  Hz,	  1H),	  6.89	  (d,	  J	  =	  8.0	  Hz,	  1H),	  6.81	  (tt,	  J	  =	  6.7,	  1.4	  Hz,	  1H),	  6.02	  (s,	  2H),	  5.78	  (s,	  1H),	  4.93	  (dd,	  J	  =	  11.9,	  2.6	  Hz,	  1H),	  3.92	  (s,	  3H),	  3.48	  (s,	  3H),	  2.84	  (dd,	  J	  =	  14.4,	  11.9	  Hz,	  1H),	  2.72	  (ddd,	  J	  =	  14.4,	  2.7,	  0.9	  Hz,	  1H);	  13C	  NMR	  (75	   MHz,	   CDCl3):	   δ	   170.1,	   168.3,	   148.5,	   147.9,	   147.6,	   135.0,	   133.1,	   130.4,	   128.6,	  128.1,	   128.0,	   121.6,	   120.3,	   115.8,	   108.4,	   107.4,	   101.2,	   78.7,	   65.6,	   59.5,	   53.5,	   52.7,	  31.5;	   IR	   (cm-­‐1):	   2946,	   2895,	   1730,	   1600,	   1492,	   1249,	   1033.	   	  HRMS	   (+ve	  ESI/APCI	  TOF,	  C27H26NO(MH+))	  	  Calc’d	  476.1704,	  Measured	  Mass	  	  476.1710.	  	  
Dimethyl	   6-­‐(4-­‐methoxyphenyl)-­‐2,3-­‐diphenyl-­‐1,2-­‐
oxazinane-­‐4,4-­‐dicarboxylate	   (7b):	   pale	   yellow	   solid,	   mp	  137-­‐139	  °C	  (394.2	  mg,	  85%	  yield);	  1H	  NMR	  (300	  MHz,	  CDCl3):	  δ	  7.67	  –	  7.55	  (m,	  2H),	  7.55	  –	  7.46	  (m,	  2H),	  7.25	  –	  7.05	  (m,	  7H),	  7.05	  –	  6.95	  (m,	  2H),	  6.85	  –	  6.76	  (m,	  1H),	  5.79	  (s,	  1H),	  4.97	  (dd,	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1H),	  2.74	  (ddd,	  J	  =	  14.4,	  2.6,	  0.9	  Hz,	  1H);	  13C	  NMR	  (75	  MHz,	  CDCl3):	  δ	  170.1,	  168.4,	  159.7,	   148.6,	   135.1,	   131.3,	   130.4,	   128.5,	   128.2,	   128.1,	   128.0,	   121.5,	   115.7,	   114.0,	  78.5,	  65.5,	  59.6,	  55.4,	  53.5,	  52.7,	  31.2;	  IR	  (cm-­‐1):	  2949,	  2892,	  2854,	  1733,	  1597,	  1242,	  1169,	   1043.	   	   HRMS	   (+ve	   ESI/APCI	   TOF,	   C27H28NO6(MH+))	   	   Calc’d	   462.1911,	  Measured	  Mass	  	  462.1927.	  
	  
Dimethyl	   2,3-­‐diphenyl-­‐6-­‐(p-­‐tolyl)-­‐1,2-­‐oxazinane-­‐4,4-­‐
dicarboxylate	   (7c):	   pale	   yellow	   solid,	   mp	   147-­‐149	   °C	  (385.9	  mg,	  87%	  yield);	  1H	  NMR	  (500	  MHz,	  CDCl3):	  δ	  7.62	  –	  7.55	  (m,	  2H),	  7.48	  –	  7.42	  (m,	  2H),	  7.31	  –	  7.24	  (m,	  2H),	  7.24	  –	  7.04	  (m,	  7H),	  6.80	  (tt,	  J	  =	  7.2,	  1.3	  Hz,	  1H),	  5.79	  (s,	  1H),	  4.99	  (dd,	  J	  =	  12.2,	  2.4	  Hz,	  1H),	  3.92	  (s,	  3H),	  3.47	  (s,	  3H),	  2.87	  (dd,	  J	  =	  14.4,	  12.2	  Hz,	  1H),	  2.76	  (ddd,	  J	  =	  14.4,	  2.5,	  0.9	  Hz,	  1H),	  2.41	  (s,	  3H);	  13C	  NMR	  (75	  MHz,	  CDCl3):	  δ	  170.1,	  168.3,	   148.6,	   138.2,	   136.3,	   135.1,	   130.4,	   129.3,	   128.5,	   128.1,	   128.0,	   126.6,	   121.5,	  115.7,	   78.7,	   65.6,	   59.5,	   53.5,	   52.7,	   31.4,	   21.3;	   IR	   (cm-­‐1):	   3028,	   2958,	   2927,	   2873,	  1735,	  1593,	  1241,	  1179,	  1076.	  	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C27H28NO5(MH+))	  	  Calc’d	  446.1962,	  Measured	  Mass	  	  446.1962.	  	  
Dimethyl	   2,3-­‐diphenyl-­‐6-­‐(o-­‐tolyl)-­‐1,2-­‐oxazinane-­‐4,4-­‐
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1H),	  5.82	  (s,	  1H),	  5.18	  (dd,	  J	  =	  11.8,	  2.4	  Hz,	  1H),	  3.94	  (s,	  3H),	  3.47	  (s,	  3H),	  2.82	  (dd,	  J	  =	  14.4,	  11.8	  Hz,	  1H),	  2.74	   (ddd,	   J	   =	  14.4,	  2.5,	  1.0	  Hz,	  1H),	  2.39	   (s,	   3H);	   13C	  NMR	   (75	  MHz,	  CDCl3):	  δ	  170.1,	  168.3,	  148.6,	  137.8,	  135.7,	  135.0,	  130.6,	  130.4,	  128.6,	  128.1,	  128.0,	   126.4,	   125.2,	   121.6,	   115.7,	   76.3,	   66.0,	   59.6,	   53.5,	   52.7,	   31.1,	   19.0;	   IR	   (cm-­‐1):	  3022,	  2955,	  2927,	  2870,	  1727,	  1600,	  1432,	  1239,	  1176,	  1070.	  	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C27H28NO5(MH+))	  	  Calc’d	  446.1962,	  Measured	  Mass	  	  446.1970.	  	  	  
Dimethyl	   6-­‐(4-­‐fluorophenyl)-­‐2,3-­‐diphenyl-­‐1,2-­‐
oxazinane-­‐4,4-­‐dicarboxylate	   (7e):	   	  white	   solid,	  mp	   134-­‐137	  °C	  (409.9	  mg,	  91%	  yield);	  1H	  NMR	  (300	  MHz,	  CDCl3):	  δ	  7.62	  –	  7.47	  (m,	  4H),	  7.24	  –	  7.04	  (m,	  9H),	  6.88	  –	  6.76	  (m,	  1H),	  5.79	  (s,	  1H),	  5.01	  (dd,	  J	  =	  11.4,	  3.2	  Hz,	  1H),	  3.93	  (s,	  3H),	  3.48	  (s,	  3H),	  2.92	  –	  2.69	  (m,	  2H);	  13C	  NMR	  (75	  MHz,	  CDCl3):	  δ	  170.0,	  168.2,	  162.7	  (d,	  J	  =	  246.9	   Hz),	   148.5,	   135.2	   (d,	   J	   =	   3.3	   Hz),	   134.9,	   130.4,	   128.6,	   128.4	   (d,	   J	   =	   8.2	   Hz),	  128.1,	  128.0,	  121.7,	  115.8,	  115.6	  (d,	  J	  =	  21.5	  Hz),	  78.2,	  65.8,	  59.5,	  53.6,	  52.7,	  31.6;	  IR	  (cm-­‐1):	   3034,	   2955,	   1739,	   1597,	   1508,	   1226,	   1176.	   HRMS	   (+ve	   ESI/APCI	   TOF,	  C26H25NO5F(MH+))	  	  Calc’d	  450.1711,	  Measured	  Mass	  	  450.1714.	  
	  
Dimethyl	   6-­‐(4-­‐chlorophenyl)-­‐2,3-­‐diphenyl-­‐1,2-­‐
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3H),	   3.48	   (s,	   3H),	   2.89	   –	   2.69	   (m,	   2H);	   13C	   NMR	   (75	  MHz,	   CDCl3):	   δ	   170.0,	   168.1,	  148.5,	   137.9,	   134.9,	   134.2,	   130.4,	   128.8,	   128.6,	   128.1,	   128.0,	   127.8,	   121.8,	   115.9,	  78.2,	   66.0,	   59.5,	   53.5,	   52.7,	   31.7;	   IR	   (cm-­‐1):	   2949,	   2898,	   1739,	   1597,	   1492,	   1230,	  1174.	   	   HRMS	   (+ve	   ESI/APCI	   TOF,	   C26H25NO5Cl(MH+))	   	   Calc’d	   466.1416,	  Measured	  Mass	  	  466.1418.	  	  
Dimethyl	   6-­‐(4-­‐bromophenyl)-­‐2,3-­‐diphenyl-­‐1,2-­‐
oxazinane-­‐4,4-­‐dicarboxylate	   (7g):	   	  white	   solid,	  mp	  180-­‐181	  °C	  (395.5	  mg,	  78%	  yield);	  1H	  NMR	  (300	  MHz,	  CDCl3):	  δ	  7.64	  –	  7.49	  (m,	  4H),	  7.48	  –	  7.39	  (m,	  2H),	  7.24	  –	  7.02	  (m,	  7H),	  6.83	  (tt,	  J	  =	  7.0,	  1.3	  Hz,	  1H),	  5.78	  (s,	  1H),	  5.00	  (dd,	  J	  =	  10.0,	  4.6	  Hz,	  1H),	  3.93	  (s,	  3H),	  3.47	  (s,	  3H),	  2.89	  –	  2.69	  (m,	  2H);	  13C	  NMR	  (75	  MHz,	  CDCl3):	  δ	  169.9,	  168.1,	  148.5,	  138.4,	  134.9,	  131.8,	  130.4,	  128.6,	  128.1,	  128.0,	  121.8,	  115.9,	  78.2,	   66.0,	   59.5,	   53.5,	   52.7,	   31.6;	   IR	   (cm-­‐1):	   2949,	   2920,	   1739,	   1591,	   1496,	   1258,	  1173,	   1068.	   	   HRMS	   (+ve	   ESI/APCI	   TOF,	   C26H25NO5Br(MH+))	   	   Calc’d	   510.0911,	  Measured	  Mass	  	  510.0902.	  	  
Dimethyl	   2,3-­‐diphenyl-­‐6-­‐(1-­‐tosyl-­‐1H-­‐indol-­‐3-­‐yl)-­‐1,2-­‐
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2H),	  6.83	  (tt,	   J	  =	  7.4,	  1.3	  Hz,	  1H),	  5.80	  (s,	  1H),	  5.28	  (ddd,	   J	  =	  11.6,	  2.9,	  1.1	  Hz,	  1H),	  3.93	  (s,	  3H),	  3.51	  (s,	  3H),	  3.02	  (dd,	  J	  =	  14.2,	  11.6	  Hz,	  1H),	  2.97	  –	  2.87	  (m,	  1H),	  2.37	  (s,	  3H);	   13C	   NMR	   (75	  MHz,	   CDCl3):	   δ	   170.0,	   168.2,	   148.6,	   145.2,	   135.3,	   135.3,	   134.8,	  130.5,	   130.0,	   129.5,	   128.6,	   128.2,	   128.0,	   127.0,	   125.1,	   123.5,	   123.4,	   121.8,	   121.0,	  120.4,	   115.8,	   113.7,	   72.3,	   66.5,	   59.4,	   53.6,	   52.7,	   29.7,	   21.6;	   IR	   (cm-­‐1):	   3060,	   3034,	  2949,	   1735,	   1597,	   1446,	   1236,	   1174,	   1135,	   680.	   	   HRMS	   (+ve	   ESI/APCI	   TOF,	  C35H33N2O7S(MH+))	  	  Calc’d	  625.2003,	  Measured	  Mass	  	  625.2018.	  	  
Dimethyl	   2,3-­‐diphenyl-­‐6-­‐(thiophen-­‐2-­‐yl)-­‐1,2-­‐
oxazinane-­‐4,4-­‐dicarboxylate	   (7i):	   	   white	   solid,	   mp	   124-­‐127	  °C	  (377.5	  mg,	  86%	  yield);	  1H	  NMR	  (300	  MHz,	  CDCl3):	  δ	  7.62	  –	  7.51	  (m,	  2H),	  7.41	  (dd,	  J	  =	  5.1,	  1.2	  Hz,	  1H),	  7.28	  –	  7.02	  (m,	  9H),	  6.82	  (tt,	  J	  =	  7.4,	  1.4	  Hz,	  1H),	  5.76	  (s,	  1H),	  5.25	  (ddd,	  
J	  =	  11.6,	  3.0,	  0.9	  Hz,	  1H),	  3.91	  (s,	  3H),	  3.49	  (s,	  3H),	  2.99	  (dd,	  J	  =	  14.3,	  11.6	  Hz,	  1H),	  2.88	  (ddd,	  J	  =	  14.3,	  3.1,	  0.8	  Hz,	  1H);	  13C	  NMR	  (75	  MHz,	  CDCl3):	  δ	  169.9,	  168.1,	  148.4,	  141.9,	  134.8,	  130.5,	  128.6,	  128.2,	  128.0,	  126.8,	  126.0,	  125.5,	  121.8,	  115.9,	  74.7,	  66.0,	  59.5,	  53.6,	  52.7,	  31.7;	   IR	   (cm-­‐1):	  2980,	  2965,	  1730,	  1600,	  1492,	  1236,	  1176,	  1147,	  701.	  	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C24H24NO5S(MH+))	  	  Calc’d	  438.1370,	  Measured	  Mass	  	  438.1376.	  	  
Dimethyl	   6-­‐(5-­‐methylfuran-­‐2-­‐yl)-­‐2,3-­‐diphenyl-­‐1,2-­‐
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7.66	  –	  7.53	  (m,	  2H),	  7.23	  –	  7.03	  (m,	  7H),	  6.87	  –	  6.74	  (m,	  1H),	  6.49	  –	  6.41	  (m,	  1H),	  6.03	  (dq,	  J	  =	  3.1,	  1.0	  Hz,	  1H),	  5.72	  (s,	  1H),	  5.01	  (dd,	  J	  =	  12.5,	  2.4	  Hz,	  1H),	  3.89	  (s,	  3H),	  3.48	  (s,	  3H),	  3.09	  (dd,	  J	  =	  14.5,	  12.5	  Hz,	  1H),	  2.70	  (ddd,	  J	  =	  14.5,	  2.6,	  0.9	  Hz,	  1H),	  2.37	  (d,	   J	   =	   1.0	  Hz,	   3H);	   13C	  NMR	   (75	  MHz,	   CDCl3):	   δ	   169.9,	   168.2,	   153.0,	   150.1,	   148.4,	  134.9,	  130.6,	  128.5,	  128.1,	  128.0,	  121.6,	  116.0,	  110.0,	  106.4,	  72.4,	  65.9,	  59.3,	  53.5,	  52.7,	   28.2,	   13.8;	   IR	   (cm-­‐1):	   3006,	   2958,	   1736,	   1591,	   1489,	   1252,	   1198,	   1154,	   755.	  HRMS	   (+ve	   ESI/APCI	   TOF,	   C25H26NO6(MH+))	   	   Calc’d	   436.1755,	   Measured	   Mass	  	  436.1769.	  
	  
Dimethyl	   3-­‐(4-­‐methoxyphenyl)-­‐2,6-­‐diphenyl-­‐1,2-­‐
oxazinane-­‐4,4-­‐dicarboxylate	   (9a):	   pale	   yellow	   solid,	   mp	  162-­‐164	   °C	   (404.7	   mg,	   88%	   yield);	   1H	   NMR	   (300	   MHz,	  CDCl3):	   δ	   7.61	   –	   7.34	   (m,	   7H),	   7.20	   –	   7.05	   (m,	   4H),	   6.87	   –	  6.77	  (m,	  1H),	  6.77	  –	  6.67	  (m,	  2H),	  5.75	  (s,	  1H),	  5.03	  (dd,	  J	  =	  11.5,	  3.1	  Hz,	  1H),	  3.92	  (s,	  3H),	  3.71	  (s,	  3H),	  3.50	  (s,	  3H),	  2.86	  (dd,	  J	  =	  14.4,	  11.5	  Hz,	  1H),	  2.77	  (ddd,	  J	  =	  14.3,	  3.2,	  0.9	  Hz,	  1H);	  13C	  NMR	  (75	  MHz,	  CDCl3):	  δ	  170.1,	  168.3,	  159.1,	   148.6,	   139.4,	   131.6,	   128.6,	   128.5,	   128.3,	   126.9,	   126.5,	   121.6,	   115.8,	   113.3,	  78.8,	  65.3,	  59.5,	  55.0,	  53.5,	  52.7,	  31.5.	   	   Spectral	  data	  was	  consistent	  with	   reported	  literature	  values.	  	  	  
Dimethyl	   2,6-­‐diphenyl-­‐3-­‐(p-­‐tolyl)-­‐1,2-­‐oxazinane-­‐4,4-­‐
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2H),	  7.51	  –	  7.33	  (m,	  5H),	  7.20	  –	  7.05	  (m,	  4H),	  7.04	  –	  6.94	  (m,	  2H),	  6.81	  (tt,	  J	  =	  7.3,	  1.5	  Hz,	  1H),	  5.77	  (s,	  1H),	  5.02	  (dd,	  J	  =	  11.7,	  2.9	  Hz,	  1H),	  3.92	  (s,	  3H),	  3.50	  (s,	  3H),	  2.86	  (dd,	  J	  =	  14.4,	  11.7	  Hz,	  1H),	  2.76	  (ddd,	  J	  =	  14.3,	  3.0,	  0.8	  Hz,	  1H),	  2.22	  (s,	  3H);	  13C	  NMR	  (75	   MHz,	   CDCl3):	   δ	   170.2,	   168.3,	   148.6,	   139.4,	   137.7,	   131.8,	   130.3,	   128.8,	   128.6,	  128.5,	   128.3,	   126.6,	   121.5,	   115.7,	   78.8,	   65.4,	   59.5,	   53.5,	   52.7,	   31.6,	   21.1;	   IR	   (cm-­‐1):	  3012,	  2965,	  2923,	  2863,	  1733,	  1597,	  1489,	  1233,	  1198,	  1052.	  	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C27H28NO5(MH+))	  	  Calc’d	  446.1962,	  Measured	  Mass	  	  446.1952.	  	  
Dimethyl	   3-­‐(4-­‐chlorophenyl)-­‐2,6-­‐diphenyl-­‐1,2-­‐
oxazinane-­‐4,4-­‐dicarboxylate	  (9c):	  white	  solid,	  150-­‐152	  °C	  (411.3	  mg,	  88%	  yield);	  1H	  NMR	  (300	  MHz,	  CDCl3):	  δ	  7.59	  –	  7.34	  (m,	  7H),	  7.22	  –	  7.11	  (m,	  4H),	  7.11	  –	  7.02	  (m,	  2H),	  6.90	  –	  6.78	  (m,	  1H),	  5.77	  (s,	  1H),	  5.03	  (dd,	  J	  =	  7.8,	  6.7	  Hz,	  1H),	  3.93	  (s,	  3H),	  3.51	  (s,	  3H),	  2.87	  –	  2.75	  (m,	  2H);	  13C	  NMR	  (75	  MHz,	  CDCl3):	  δ	  169.8,	  168.1,	  148.3,	   139.1,	   134.1,	   133.5,	   131.7,	   128.7,	   128.7,	   128.5,	   128.3,	   126.5,	   121.9,	   115.8,	  78.8,	   65.3,	   59.4,	   53.6,	   52.8,	   31.5;	   IR	   (cm-­‐1):	   3034,	   2952,	   2876,	   1733,	   1599,	   1486,	  1235,	  1198,	  1181.	  	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C26H25NO5Cl(MH+))	  	  Calc’d	  466.1416,	  Measured	  Mass	  	  466.1421.	  	  
Dimethyl	   2,6-­‐diphenyl-­‐3-­‐(1-­‐tosyl-­‐1H-­‐indol-­‐3-­‐yl)-­‐1,2-­‐
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7.48	  (m,	  3H),	  7.48	  –	  7.38	  (m,	  3H),	  7.24	  –	  7.12	  (m,	  2H),	  7.11	  –	  6.99	  (m,	  6H),	  6.85	  –	  6.71	  (m,	  1H),	  6.12	  (s,	  1H),	  5.08	  (dd,	  J	  =	  11.5,	  3.0	  Hz,	  1H),	  3.96	  (s,	  3H),	  3.14	  (s,	  3H),	  2.84	  (ddd,	  J	  =	  14.5,	  3.1,	  0.9	  Hz,	  1H),	  2.75	  (dd,	  J	  =	  14.5,	  11.5	  Hz,	  1H),	  2.28	  (s,	  3H);	  13C	  NMR	  (75	  MHz,	  CDCl3):	  δ	  169.7,	  167.9,	  148.6,	  144.6,	  139.0,	  134.8,	  134.0,	  131.2,	  129.7,	  128.9,	   128.6,	   128.5,	   127.3,	   126.5,	   126.4,	   124.6,	   123.1,	   122.1,	   119.2,	   116.0,	   115.6,	  113.5,	  79.1,	  58.8,	  58.6,	  53.6,	  52.6,	  31.9,	  21.;	  IR	  (cm-­‐1):	  3066,	  3031,	  2955,	  2923,	  1736,	  1597,	  1445,	  1230,	  1173,	  1119,	  660.	  	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C35H33N2O7S(MH+))	  	  Calc’d	   476.1704,	   Measured	   Mass	   	   476.1710.Calc’d	   625.2003,	   Measured	   Mass	  	  625.2003.	  	  
2.	  Experimental	  Information	  for	  the	  Mukaiyama-­‐Mannich	  Reaction	  
General	  Information.	  Unless	  otherwise	  noted,	  all	  commercial	  materials	  were	  used	  without	   purification.	   Calcium	   triflate,	   N,α-­‐Diphenyl	   nitrone,	   and	   1-­‐Phenyl-­‐1-­‐trimethylsiloxyethylene,	   	   1-­‐(Trimethylsiloxy)cyclopentene,	   1-­‐(Trimethylsiloxy)cyclophexene,	   and	   (1-­‐Tert-­‐Butylvinyloxy)trimentylsilane	   were	  obtained	  from	  commercial	  sources	  and	  used	  without	   further	  purification.	  Nitrones	  were	   synthesized	   according	   to	   literature	   procedures.	   Diastereomeric	   ratios	   were	  determined	   by	   1HNMR.	   NMR	   data	   for	   the	  major	   diastereomer	   has	   been	   reported.	  Minor	  diastereomers	  were	  not	  able	  to	  be	  isolated.	  	  	  
General	  Procedure	  for	  the	  Addition	  of	  Nitrones	  to	  Silyl	  Enol	  Ethers	  	  In	  an	  inert	  glovebox,	  calcium	  triflate	  (6.8	  mg,	  0.02	  mmols,	  0.02	  eq)	  was	  added	  to	  a	  3	  mL	  conical	  glass	  vial	  with	  a	  	  stir	  bar.	  After	  the	  vial	  was	  removed	  from	  the	  glove	  box,	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nitrone	  (1.0	  eq,	  1.0	  mmol),	  silyl	  enol	  ether	  (1.5	  mmols,	  1.5	  eq),	  and	  dry	  MeCN	  (1.0	  mL,	  1.0	  M)	  were	  added.	  The	  reaction	  solution	  was	  heated	  to	  50	  °C,	  and	  the	  reaction	  progress	  was	  monitored	  by	  TLC.	  Upon	  completion,	  the	  vial	  was	  removed	  from	  the	  heat	  and	  cooled	  to	  room	  temperature	  while	  stirring.	  The	  reaction	  was	  loaded	  directly	  onto	  a	  silica	  gel	  column	  and	  purified	  by	  flash	  chromatography	  (10-­‐20%	  EtOAc	  or	  ether	  in	  hexanes).	  	  	  In	  an	  inert	  glovebox,	  calcium	  triflate	  (16.9mg,	  0.05	  mmols,	  0.05	  eq)	  was	  added	  to	  a	  3	  mL	  conical	  glass	  vial	  with	  a	  	  stir	  bar.	  After	  the	  vial	  was	  removed	  from	  the	  glove	  box,	  nitrone	  (1.0	  eq,	  1.0	  mmol),	  silyl	  enol	  ether	  (1.5	  mmols,	  1.5	  eq),	  and	  dry	  MeCN	  (1.0	  mL,	  1.0	  M)	  were	  added.	  The	  reaction	  solution	  was	  heated	  to	  70	  °C,	  and	  the	  reaction	  progress	  was	  monitored	  by	  TLC.	  Upon	  completion,	  the	  vial	  was	  removed	  from	  the	  heat	  and	  cooled	  to	  room	  temperature	  while	  stirring.	  The	  reaction	  was	  loaded	  directly	  onto	  a	  silica	  gel	  column	  and	  purified	  by	  flash	  chromatography	  (10-­‐20%	  ether	  in	  hexanes).	  	  	  
1,3-­‐diphenyl-­‐3-­‐
(phenyl((trimethylsilyl)oxy)amino)propan-­‐1-­‐one	  (13):	  (384.5	  mg,	  98%	  yield);	  1H	  NMR	  (500	  MHz,	  Chloroform-­‐d)	  δ	  7.91	  –	  7.86	  (m,	  2H),	  7.56	  –	  7.50	  (m,	  1H),	  7.42	  (dd,	  J	  =	  8.3,	  7.1	  Hz,	  2H),	  7.33	  –	  7.17	  (m,	  8H),	  7.15	  –	  7.09	  (m,	  2H),	  6.98	  (tt,	  J	  =	  7.2,	  1.2	  Hz,	  1H),	  5.11	  (dd,	  J	  =	  8.5,	  4.9	  Hz,	  1H),	  3.73	  (dd,	  J	  =	  17.2,	  8.5	  Hz,	  1H),	  3.60	  (dd,	  J	  =	  17.2,	  4.9	  Hz,	  1H),	  -­‐0.13	  (s,	  9H);	  13C	  NMR	  (75	  MHz,	  CDCl3)	  δ	  197.95,	  152.31,	  138.80,	  137.15,	  132.88,	  129.50,	  128.46,	  128.16,	  
NMe3SiO O
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128.00,	  127.81,	  127.53,	  123.48,	  120.29,	  69.45,	  37.70,	  -­‐0.70;	  Spectral	  data	  was	  consistent	  with	  reported	  literature	  values.	  iv	  	  
	  4,4-­‐dimethyl-­‐1-­‐phenyl-­‐3-­‐
(phenyl((trimethylsilyl)oxy)amino)pentan-­‐1-­‐one	  (16a):	  (351.6	  mg,	  95%	  yield);	  1H	  NMR	  (300	  MHz,	  Chloroform-­‐d)	  δ	  7.28	  –	  7.15	  (m,	  7H),	  7.11	  –	  7.05	  (m,	  2H),	  7.00	  –	  6.93	  (m,	  1H),	  4.90	  (dd,	  J	  =	  9.5,	  3.8	  Hz,	  1H),	  3.42	  (dd,	  J	  =	  17.8,	  9.4	  Hz,	  1H),	  3.00	  (dd,	  J	  =	  17.8,	  3.8	  Hz,	  1H),	  1.01	  (s,	  9H),	  -­‐0.12	  (s,	  9H);	  13C	  NMR	  (75	  MHz,	  CDCl3)	  δ	  213.20,	  152.40,	  139.02,	  129.60,	  128.08,	  127.65,	  127.38,	  123.33,	  120.26,	  69.06,	  44.22,	  36.71,	  26.29,	  -­‐0.65;	  IR	  (cm-­‐1):	  3040,	  2962,	  1695,	  1486,	  1343,	  1250,	  1099,	  1074.	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C22H31NO2Si(MH+))	  Calcd	  370.2197,	  Measured	  Mass	  370.2208.	  	  	  
2-­‐
(phenyl(phenyl((trimethylsilyl)oxy)amino)methyl)cyclopen
tanone	  (16b):	  	  (311.1	  mg,	  88%	  yield);	  1H	  NMR	  (300	  MHz,	  Chloroform-­‐d)	  δ	  7.24	  –	  6.92	  (m,	  10H),	  4.55	  (d,	  J	  =	  6.2	  Hz,	  1H),	  2.69	  (tdd,	  J	  =	  8.9,	  6.2,	  1.2	  Hz,	  1H),	  2.42	  –	  1.96	  (m,	  5H),	  1.89	  –	  1.66	  (m,	  1H),	  -­‐0.06	  (s,	  9H);	  13C	  NMR	  (75	  MHz,	  CDCl3)	  δ	  217.47,	  152.78,	  138.27,	  129.69,	  127.99,	  127.46,	  127.31,	  124.30,	  122.00,	  73.84,	  52.45,	  37.95,	  26.94,	  20.31,	  -­‐0.20;	  IR(cm-­‐1):	  3032,	  2958,	  1744,	  1593,	  1491,	  1450,	  1254,	  1156.	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C21H27NO2Si(MH+))	  Calcd	  354.1884,	  Measured	  Mass	  354.1891.	  
NMe3SiO O
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2-­‐
(phenyl(phenyl((trimethylsilyl)oxy)amino)methyl)cyclohex
anone	  (16c):	  	  (213.5	  mg,	  58%	  yield);	  1H	  NMR	  (500	  MHz,	  Chloroform-­‐d)	  δ	  7.20	  –	  7.07	  (m,	  5H),	  6.99	  –	  6.87	  (m,	  3H),	  6.86	  –	  6.80	  (m,	  2H),	  4.46	  (d,	  J	  =	  11.1	  Hz,	  1H),	  3.45	  –	  3.35	  (m,	  1H),	  2.62	  –	  2.51	  (m,	  1H),	  2.29	  –	  1.76	  (m,	  5H),	  0.05	  (s,	  9H);	  13C	  NMR	  (75	  MHz,	  CDCl3)	  δ	  212.02,	  152.97,	  135.40,	  130.08,	  127.98,	  127.21,	  126.88,	  123.11,	  119.89,	  73.19,	  52.93,	  42.35,	  32.71,	  29.32,	  23.59,	  -­‐0.19;	  IR	  (cm-­‐1):	  3685,	  3060,	  3035,	  2941,	  2864,	  1712,	  1601,	  1495,	  1458,	  1249,	  1209,	  1127,	  1061,	  1033,	  1004.	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C22H29NO2Si(MH+))	  Calcd	  368.2040,	  Measured	  Mass	  368.2043.	  	  	  
3-­‐(4-­‐methoxyphenyl)-­‐1-­‐phenyl-­‐3-­‐
(phenyl((trimethylsilyl)oxy)amino)propan-­‐1-­‐one	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1-­‐phenyl-­‐3-­‐(phenyl((trimethylsilyl)oxy)amino)-­‐3-­‐(p-­‐




(14c)	  (406.2	  mg,	  96%	  yield);	  1H	  NMR	  (500	  MHz,	  Chloroform-­‐d)	  δ	  7.90	  –	  7.86	  (m,	  2H),	  7.57	  –	  7.51	  (m,	  1H),	  7.43	  (dd,	  J	  =	  8.4,	  7.1	  Hz,	  2H),	  7.25	  –	  7.17	  (m,	  6H),	  5.04	  (dd,	  J	  =	  8.5,	  5.0	  Hz,	  1H),	  3.69	  (dd,	  J	  =	  17.3,	  8.6	  Hz,	  1H),	  3.60	  (dd,	  J	  =	  17.3,	  4.9	  Hz,	  1H),	  -­‐0.10	  (s,	  9H);	  
13C	  NMR	  (75	  MHz,	  CDCl3)	  δ	  197.61,	  152.11,	  137.11,	  136.97,	  133.32,	  133.06,	  130.82,	  128.54,	  128.26,	  127.96,	  127.93,	  123.74,	  120.33,	  68.87,	  38.22,	  -­‐0.61;	  Spectral	  data	  was	  consistent	  with	  reported	  literature	  values.v	  	  	  
	  
1-­‐phenyl-­‐3-­‐(phenyl((trimethylsilyl)oxy)amino)-­‐3-­‐(1-­‐
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(14e):	  441.8	  mg,	  94%	  yield);	  1H	  NMR	  (500	  MHz,	  Chloroform-­‐d)	  δ	  7.90	  –	  7.85	  (m,	  2H),	  7.57	  –	  7.51	  (m,	  1H),	  7.47	  –	  7.40	  (m,	  2H),	  7.39	  –	  7.33	  (m,	  2H),	  7.24	  –	  7.18	  (m,	  2H),	  7.16	  –	  7.08	  (m,	  4H),	  7.00	  (tt,	  J	  =	  7.2,	  1.2	  Hz,	  1H),	  5.03	  (dd,	  J	  =	  8.5,	  5.1	  Hz,	  1H),	  3.69	  (dd,	  J	  =	  17.3,	  8.5	  Hz,	  1H),	  3.60	  (dd,	  J	  =	  17.3,	  5.0	  Hz,	  1H),	  -­‐0.10	  (s,	  9H);	  13C	  NMR	  (75	  MHz,	  CDCl3)	  δ	  197.57,	  152.09,	  137.60,	  136.95,	  133.07,	  131.18,	  130.88,	  128.55,	  128.26,	  127.96,	  123.75,	  121.53,	  120.32,	  68.92,	  38.21,	  -­‐0.61;	  Spectral	  data	  was	  consistent	  with	  reported	  literature	  values.	  iv	  	  
3-­‐(naphthalen-­‐1-­‐yl)-­‐1-­‐phenyl-­‐3-­‐
(phenyl((trimethylsilyl)oxy)amino)propan-­‐1-­‐one	  
(14f):	  (410.6	  mg,	  93%	  yield);	  1H	  NMR	  (300	  MHz,	  Chloroform-­‐d)	  δ	  8.49	  (d,	  J	  =	  8.5	  Hz,	  1H),	  7.92	  –	  7.73	  (m,	  4H),	  7.64	  –	  7.18	  (m,	  13H),	  7.04	  –	  6.94	  (m,	  1H),	  6.06	  (dd,	  J	  =	  8.7,	  4.7	  Hz,	  1H),	  4.03	  (dd,	  J	  =	  17.2,	  8.7	  Hz,	  1H),	  3.61	  (dd,	  J	  =	  17.2,	  4.7	  Hz,	  1H),	  -­‐0.38	  (s,	  9H);	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128.68,	  128.46,	  128.43,	  128.00,	  126.11,	  126.02,	  125.33,	  124.72,	  123.86,	  123.41,	  119.75,	  64.51,	  36.41,	  -­‐0.97;	  IR(cm	  -­‐1):	  3861,	  3652,	  3060,	  2962,	  2905,	  1684,	  1601,	  1491,	  1450,	  1348,	  1291,	  1250,	  1213,	  1005.	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C28H29NO2Si(MH+))	  Calcd	  440.2040,	  Measured	  Mass	  440.2054.	  	  
	  
1-­‐phenyl-­‐3-­‐(phenyl((trimethylsilyl)oxy)amino)-­‐3-­‐(o-­‐
tolyl)propan-­‐1-­‐one	  (14g):	  (339.4	  mg,	  84%	  yield);	  1H	  NMR	  (500	  MHz,	  Chloroform-­‐d)	  δ	  7.86	  –	  7.81	  (m,	  2H),	  7.54	  –	  7.48	  (m,	  1H),	  7.40	  (dd,	  J	  =	  8.4,	  7.1	  Hz,	  2H),	  7.34	  –	  7.28	  (m,	  1H),	  7.28	  –	  7.19	  (m,	  5H),	  7.17	  –	  7.06	  (m,	  3H),	  6.99	  (tt,	  J	  =	  6.6,	  2.1	  Hz,	  1H),	  5.39	  (dd,	  J	  =	  9.1,	  4.4	  Hz,	  1H),	  3.92	  (dd,	  J	  =	  17.3,	  9.0	  Hz,	  1H),	  3.42	  (dd,	  J	  =	  17.3,	  4.4	  Hz,	  1H),	  2.51	  (s,	  3H),	  -­‐0.26	  (s,	  9H);	  13C	  NMR	  (75	  MHz,	  CDCl3)	  δ	  198.28,	  152.65,	  138.07,	  137.26,	  137.19,	  132.80,	  130.37,	  128.40,	  128.35,	  128.21,	  127.94,	  127.47,	  125.31,	  123.34,	  119.78,	  65.05,	  36.39,	  19.76,	  -­‐0.98;	  IR	  (cm-­‐1):	  3027,	  2954,	  2893,	  1687,	  1597,	  1487,	  1450,	  1339,	  1291,	  1258,	  1213,	  1021.	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C25H29NO2Si(MH+))	  Calcd	  404.2040,	  Measured	  Mass	  404.2052.	  	  	  
3-­‐(5-­‐methylfuran-­‐2-­‐yl)-­‐1-­‐phenyl-­‐3-­‐
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3.41	  (dd,	  J	  =	  17.0,	  4.1	  Hz,	  1H),	  2.27	  (d,	  J	  =	  1.0	  Hz,	  3H),	  -­‐0.03	  (s,	  9H);	  13C	  NMR	  (75	  MHz,	  CDCl3)	  δ	  197.81,	  151.74,	  151.27,	  150.95,	  136.96,	  132.92,	  128.44,	  128.25,	  128.09,	  123.30,	  119.66,	  109.44,	  106.19,	  63.29,	  35.61,	  13.58,	  -­‐0.91;	  IR(cm-­‐1):	  3068,	  2966,	  1691,	  1601,	  1491,	  1450,	  1344,	  1250,	  1221,	  1070.	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C23H27NO3Si(MH+))	  Calcd	  394.1833,	  Measured	  Mass	  394.1846.	  	  
	  
1-­‐phenyl-­‐3-­‐(phenyl((trimethylsilyl)oxy)amino)-­‐3-­‐
(thiophen-­‐2-­‐yl)propan-­‐1-­‐one	  (24i)	  (301.0	  mg,	  76%	  yield);	  1H	  NMR	  (300	  MHz,	  Chloroform-­‐d)	  δ	  7.96	  –	  7.87	  (m,	  2H),	  7.59	  –	  7.50	  (m,	  1H),	  7.50	  –	  7.39	  (m,	  2H),	  7.28	  –	  7.08	  (m,	  5H),	  7.04	  –	  6.95	  (m,	  1H),	  6.88	  –	  6.73	  (m,	  2H),	  5.42	  –	  5.33	  (m,	  1H),	  3.65	  (dd,	  J	  =	  6.6,	  1.7	  Hz,	  2H),	  -­‐0.01	  (s,	  9H);	  13C	  NMR	  (75	  MHz,	  CDCl3)	  δ	  197.28,	  151.96,	  141.49,	  136.98,	  133.04,	  128.54,	  128.17,	  128.04,	  126.59,	  125.86,	  125.07,	  123.59,	  120.02,	  65.20,	  -­‐0.61;	  IR(cm-­‐1):	  3068,	  2958,	  1683,	  1597,	  1486,	  1450,	  1352,	  1287,	  1254,	  1217.	  HRMS	  (+ve	  ESI/APCI	  TOF,	  C22H25NO2SSi(MH+)	  Calcd	  396.1448,	  Measured	  Mass	  396.1456.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  i	  Kang,	  Y.	  B.;	  Sun,	  X.	  L.;	  Tang,	  Y.	  Angew.	  Chem.	  Int.	  Ed.	  2007,	  46,	  3918-­‐3921.	  
ii A peak for the 13C NMR in CDCl3 was obscured under the CDCl3 peaks. It was 
confirmed by 13C NMR in C6D6 at 77.12 ppm.  iii	  Sapeta,	  K.;	  Kerr,	  M.	  A.	  J.	  Org.	  Chem.	  2007,	  72,	  8597-­‐8599.	  iv	  Downey,	  C.	  W.;	  Dombrowski,	  C.	  M.;	  Maxwell,	  E.	  N.;	  Safran,	  C.	  L.;	  Akomah,	  O.	  A.	  Eur.	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4.	  Abbreviation	  List	  	  
	  DA:	  Donor-­‐Acceptor	  	  CaI2:	  Calcium	  Iodide	  	  Ca(acac)2:	  Calcium	  Acetylacetonate	  	  Ca(OMe)2:	  Calcium	  Methoxide	  	  Ca(OAc)2:	  Calcium	  Acetate	  	  Ca(neodec):	  Calcium	  Neodecanoate	  	  Ca(OTf)2:	  Calcium	  Triflate	  	  CH3CN:	  Acetonitrile	  	  Ca(NTf2)2:	  Calcium	  Triflamide	  	  
